Schneider National [SNDR] vs Rxo [RXO] Detailed Stock Comparison

Schneider National Inc.

NYSE
Loading...

Rxo Inc.

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Schneider National Inc. wins in 13 metrics, Rxo Inc. wins in 6 metrics, with 0 ties. Schneider National Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Schneider National Inc. Rxo Inc. Better
P/E Ratio (TTM) 51.07 645.33 Schneider National Inc.
Price-to-Book Ratio 1.74 2.04 Schneider National Inc.
Debt-to-Equity Ratio 16.43 43.48 Schneider National Inc.
PEG Ratio -1.62 5.16 Rxo Inc.
EV/EBITDA 9.42 34.81 Schneider National Inc.
Profit Margin (TTM) 1.83% -1.74% Schneider National Inc.
Operating Margin (TTM) 2.61% -0.61% Schneider National Inc.
EBITDA Margin (TTM) 2.61% N/A N/A
Return on Equity 3.45% -6.34% Schneider National Inc.
Return on Assets (TTM) 2.16% -0.13% Schneider National Inc.
Free Cash Flow (TTM) $182.80M $-8.00M Schneider National Inc.
Dividend Yield 1.69% N/A N/A
1-Year Return 59.63% 84.69% Rxo Inc.
Price-to-Sales Ratio (TTM) 0.93 0.55 Rxo Inc.
Enterprise Value $5.54B $3.79B Schneider National Inc.
EV/Revenue Ratio 0.98 0.66 Rxo Inc.
Gross Profit Margin (TTM) 8.03% 13.00% Rxo Inc.
Revenue per Share (TTM) $32 $34 Rxo Inc.
Earnings per Share (Diluted) $0.59 $-0.59 Schneider National Inc.
Beta (Stock Volatility) 1.06 1.53 Schneider National Inc.
Short % of Float 10.60% 24.27% Schneider National Inc.

Schneider National Inc. vs Rxo Inc. Stock Performance Analysis

Loading Price Chart...

SNDR
RXO

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Schneider National Inc.-1.95%-2.76%18.00%57.76%38.82%39.75%
Rxo Inc.-2.26%-1.28%48.26%131.69%84.73%115.81%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Schneider National Inc.59.63%42.11%80.55%102.32%102.32%102.32%
Rxo Inc.84.69%26.85%31.86%31.86%31.86%31.86%

Performance & Financial Health Analysis: Schneider National Inc. vs Rxo Inc.

MetricSNDRRXO
Market Information
Market Cap i$5.28B$3.18B
Market Cap CategoryMid capMid cap
10 Day Avg. Volume i1,337,2861,942,255
90 Day Avg. Volume i1,102,3051,877,215
Last Close$37.69$27.71
52 Week Range$20.11 - $39.27$10.43 - $29.86
% from 52W High-4.02%-7.20%
All-Time High$39.27 (Jun 09, 2026)$32.82 (Jul 29, 2024)
% from All-Time High-4.02%-15.57%
Growth Metrics
Quarterly Revenue Growth0.05%-0.12%
Quarterly Earnings Growth-0.32%-0.12%
Financial Health
Profit Margin (TTM) i0.02%-0.02%
Operating Margin (TTM) i0.03%-0.01%
Return on Equity (TTM) i0.03%-0.06%
Debt to Equity (MRQ) i16.4343.48
Cash & Liquidity
Book Value per Share (MRQ)$17.28$9.39
Cash per Share (MRQ)$1.39$0.10
Operating Cash Flow (TTM) i$637.40M$51.00M
Levered Free Cash Flow (TTM) i$26.36M$42.75M
Dividends
Last 12-Month Dividend Yield i1.69%N/A
Last 12-Month Dividend i$0.40N/A

Valuation & Enterprise Metrics Analysis: Schneider National Inc. vs Rxo Inc.

MetricSNDR (Apr 24, 2026)RXO (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i51.07645.33
Forward P/E i21.2949.16
PEG Ratio i-1.625.16
Price to Sales (TTM) i0.930.55
Price to Book (MRQ) i1.742.04
Market Capitalization
Market Capitalization i$5.28B$3.18B
Enterprise Value i$5.54B$3.79B
Enterprise Value Metrics
Enterprise to Revenue i0.980.66
Enterprise to EBITDA i9.4234.81
Risk & Other Metrics
Beta i1.061.53
Book Value per Share (MRQ) i$17.28$9.39

Financial Statements Comparison: Schneider National Inc. vs Rxo Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricSNDR (2025)RXO (2025)
Revenue/Sales i5.67B5.74B
Cost of Goods Sold i5.18B4.92B
COGS % of Revenue i91.4%85.6%
Gross Profit i489.50M825.00M
Gross Margin i8.6%14.4%
Research & Development iN/AN/A
Operating Income (EBIT) i168.90M-7.00M
Operating Margin i3.0%-0.1%
EBITDA i621.80M108.00M
EBITDA Margin i11.0%1.9%
Pre-Tax Income i138.00M-115.00M
Pre-Tax Income % of Revenue i2.4%-2.0%
Income Tax i34.40M-15.00M
Income Tax % of Revenue i0.6%-0.3%
Net Income (Profit) i103.60M-100.00M
Profit Margin i1.8%-1.7%

Balance Sheet & Liquidity Metrics

MetricSNDR (2025)RXO (2025)
Cash & Equivalents i201.50M17.00M
Total Current Assets i1.18B1.32B
Total Current Assets % of Revenue i20.8%22.9%
Total Current Liabilities i555.80M1.04B
Total Current Liabilities % of Revenue i9.8%18.1%
Long-Term Debt i390.90M578.00M
Long-Term Debt % of Revenue i6.9%10.1%
Total Shareholders Equity i3.02B1.54B
Retained Earnings i1.52B-384.00M
Retained Earnings % of Revenue i26.8%-6.7%
Property, Plant & Equipment i390.80M238.00M

Cash Flow Statement Comparison

MetricSNDR (2025)RXO (2025)
Operating Cash Flow i651.10M33.00M
Operating Cash Flow % of Revenue i11.5%0.6%
Capital Expenditures i-359.00M-57.00M
Free Cash Flow i182.80M-8.00M
FCF Margin i3.2%-0.1%
Debt Repayment i-271.40M-535.00M
Common Stock Repurchase i-14.60M0

Short Interest & Institutional Ownership Analysis

MetricSNDRRXO
Shares Short i5.68M13.95M
Short Ratio i5.587.29
Short % of Float i10.60%24.27%
Shares Outstanding i175.02M164.16M
Float Shares i67.52M125.56M
% Held by Insiders i50.16%0.86%
% Held by Institutions i75.18%107.88%
% Held by Public i-25.34%-8.74%

Dividend Analysis & Yield Comparison: Schneider National Inc. vs Rxo Inc.

MetricSNDRRXO
Last 12-Month Dividend i$0.40N/A
Last 12-Month Dividend Yield i1.69%N/A
3-Year Avg Annual Dividend i$0.39N/A
3-Year Avg Dividend Yield i0.38%N/A
3-Year Total Dividends i$1.17N/A
Ex-Dividend DateMar 13, 2026N/A